Ceftolozane/tazobactam heteroresistance in cystic fibrosis-related Pseudomonas aeruginosa infections
ML Monogue, JM Sanders, CA Pybus… - JAC-Antimicrobial …, 2023 - academic.oup.com
Objectives Cystic fibrosis (CF) patients are often colonized with Pseudomonas aeruginosa.
During treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
During treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
Ceftolozane/tazobactam heteroresistance in cystic fibrosis-related Pseudomonas aeruginosa infections
ML Monogue, J Sanders… - JAC …, 2023 - utsouthwestern.elsevierpure.com
Objectives: Cystic fibrosis (CF) patients are often colonized with Pseudomonas aeruginosa.
During treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
During treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
[HTML][HTML] Ceftolozane/tazobactam heteroresistance in cystic fibrosis-related Pseudomonas aeruginosa infections
ML Monogue, JM Sanders, CA Pybus… - JAC-Antimicrobial …, 2023 - ncbi.nlm.nih.gov
Objectives Cystic fibrosis (CF) patients are often colonized with Pseudomonas aeruginosa.
During treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
During treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
Ceftolozane/tazobactam heteroresistance in cystic fibrosis-related Pseudomonas aeruginosa infections
ML Monogue, JM Sanders… - JAC-antimicrobial …, 2023 - pubmed.ncbi.nlm.nih.gov
Objectives Cystic fibrosis (CF) patients are often colonized with Pseudomonas aeruginosa.
During treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
During treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
[PDF][PDF] Ceftolozane/tazobactam heteroresistance in cystic fibrosis-related Pseudomonas aeruginosa infections
ML Monogue, JM Sanders, CA Pybus… - JAC-Antimicrobial …, 2023 - academic.oup.com
Objectives Cystic fibrosis (CF) patients are often colonized with Pseudomonas aeruginosa.
During treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
During treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
[PDF][PDF] JAC-Antimicrobial Resistance
ML Monogue, JM Sanders, CA Pybus, J Kim… - in …, 2023 - pdfs.semanticscholar.org
Objectives: Cystic fibrosis (CF) patients are often colonized with Pseudomonas aeruginosa.
During treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
During treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
Ceftolozane/tazobactam heteroresistance in cystic fibrosis-related Pseudomonas aeruginosa infections.
ML Monogue, JM Sanders, CA Pybus… - Jac-antimicrobial …, 2023 - europepmc.org
Objectives Cystic fibrosis (CF) patients are often colonized with Pseudomonas aeruginosa.
During treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
During treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
Ceftolozane/tazobactam heteroresistance in cystic fibrosis-related Pseudomonas aeruginosa infections.
ML Monogue, JM Sanders, CA Pybus… - Jac-antimicrobial …, 2023 - europepmc.org
Cystic fibrosis (CF) patients are often colonized with Pseudomonas aeruginosa. During
treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …
treatment, P. aeruginosa can develop subpopulations exhibiting variable in vitro …